Pediatric Meeting Agenda | Controlled Release Society (CRS)

November 2, 2021

9:00 AM - Welcome & Opening Remarks Andrew Lewis, Quotient Sciences

Session 1: 9:15 - 10:15 AM
Challenges of Drug Administration to Pediatric Patients Louise Bracken, Co-Director Paediatric Medicines Research Unit, Alder Hey Children’s NHS Foundation Trust
Co-administration of Pediatric Medicines with Food and Drinks Nikoletta Fotaki, Reader in Biopharmaceutics, University of Bath
BREAK: 10:15 - 11:00 AM
Session 2: 11:00 AM - 12:30 PM
Developing ZENEO® Needle-free Auto-injector for Pediatric Use Olivier Giré, Chief Operating Officer Specialty Pharma, Crossject Donald Zinn, Vice President US Business, Crossject USA Inc Henri Bodeau, Crossject
Pediatric Pharmaceutics Catherine Tuleu, Professor in Pediatric Pharmaceutics, University College London School of Pharmacy
A Matter of Taste: Development of Palatable Paediatric Dosage Forms David Clapham, Independent Pharmaceutical Consultant
BREAK: 12:30 - 12:45 PM
Session 3: 12:45 - 2:15 PM
ABC's of Pediatric CMC - An Industry Perspective Stuart Charlton, Associate Scientific Director, Bristol Myers Squibb
Minitablets: Manufacturing, Characterization and Future Opportunities Ron Smith, Principal, Pharmawyze, LLC
The Phillips-Medisize Mini-tablet Dispenser Bjørn Knud Andersen, Director Front-End Innovation, Phillips-Medisize
BREAK: 2:15 - 3:00 PM
Session 4: 3:00 - 4:00 PM
How can we estimate food effects in children? Simulated Pediatric Breakfast Media (SPBM) Sandra Klein, Professor of Pharmaceutical Technology, University of Greifswald
Development of an oral infant friendly Amphothericin B formulation Ragna Berthelsen, Associate Professor, University of Copenhagen

November 3, 2021

9:00 AM - Welcome & Opening Remarks Cornell Stamoran, Catalent Pharma Solutions

Session 1: 9:15 - 10:15 AM
Insights and Lessons from the Development of Alkindi Helen Coope, European Medical Affairs Manager, Diurnal
Moxidectin Pediatric Formulation Development Nicky Konstantopoulos, Associate Director, CMC, Medicines Development for Global Health
BREAK: 10:15 - 11:00 AM
Session 2: 11:00 AM - 12:30 PM
MicroCoatTM – Production of versatile micropellets for pediatric applications Fang Liu, Founder & Director, Fluid Pharma
Design and Delivery of Paediatric Early Phase Clinical Trials - Learning from 10 years of Alder Hey Clinical Research Facility Dan Hawcutt, Senior Lecturer Paediatric Clinical Pharmacology, University of Liverpool
Development and Characterization of Pediatric Formulations Kingsley Iyoha, Director, Development, Pharmaceutical Sciences, Quotient Sciences
BREAK: 12:30 - 12:45 PM
Session 3: 12:45 - 2:15 PM
Developing Gene Therapy for Lethal Paediatric Neurometabolic Diseases Ahad Rahim, Professor of Translational Neuroscience, University College London
Excipient Selection for Pediatric Drug Products Kevin Hughes, Regulatory Affairs and QA Manager, Colorcon Ltd.
Overview of EU and FDA Pediatric Regulations Gloria Garcia Palacios, Global Regulatory Affairs - EU Head I&I, Sanofi
BREAK: 2:15 - 3:00 PM
Session 4: 3:00 - 4:00 PM
Oral Multiparticulates as a Platform Approach for Pediatric Drug Development Matthew Santangelo, Principal Scientist, Pfizer Inc.
Drug Delivery for Children with Aggressive Brain Cancer Maria Kavallaris, Director Australian Centre for NanoMedicine UNSW Sydney and Head of Translational Cancer Nanomedicine, Children's Cancer Institute